Page last updated: 2024-08-18

pyrroles and cardiovascular agents

pyrroles has been researched along with cardiovascular agents in 41 studies

Research

Studies (41)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (14.63)	18.7374
1990's	5 (12.20)	18.2507
2000's	17 (41.46)	29.6817
2010's	11 (26.83)	24.3611
2020's	2 (4.88)	2.80

Authors

Authors	Studies
Adachi, H; Kodama, K; Ogawa, T; Ohhara, H	1
Dzwonczyk, S; Grover, GJ; Sleph, PG	1
Coldwell, MC; Cooper, SM; Hamilton, TC; Howlett, DR; Wilson, C	1
Challinor-Rogers, JL; Hay, TK; McPherson, GA	1
Chiba, S; Furukawa, Y; Inoue, Y; Sawaki, S; Takayama, S	1
Brasch, H	1
Alexy, T; Battyany, I; Halmosi, R; Hideg, K; Horvath, B; Kesmarky, G; Marton, Z; Toth, K; Vekasi, J	1
Lewin, JJ; Nappi, JM; Taylor, MH	1
Ammirati, F; Colivicchi, F; Guido, V; Montefoschi, N; Santini, M; Tubaro, M; Varveri, A	1
Malik, P	1
FREIS, ED; LILIENFIELD, LS; PARTENOPE, EA; ROSE, JC	1
BUU-HOI, NP; CAVIER, R; RIPS, R	2
BUU-HOUI, NP; DERAPPE, C; RIPS, R	1
GAVEND, M; GAVEND, MR; MERCIER, F	1
Daida, H; Kurata, T; Miyauchi, K; Okazaki, S; Sato, H; Shimada, K; Yokoyama, T	1
Laustsen, G; Wimmett, L	1
Courtney, BK; Fitzgerald, PJ; Koizumi, T; Komiyama, N; Komuro, I; Kuriyama, N; Nakayama, T; Nameki, M; Namikawa, S; Yokoyama, M	1
Di Sciascio, G; Pasceri, V; Patti, G	1
Andrade, RJ; Barriocanal, A; Borraz, Y; Costa, J; Durán, JA; Fernández, MC; García-Cortés, M; García-Muņoz, B; Guarner, C; Hidalgo, R; Kaplowitz, N; Lucena, MI; Muņoz-Yagüe, T; Pachkoria, K; Pelaez, G; Planas, R; Rodrigo, L; Romero-Gomez, M; Salmerón, J	1
Fukunami, M; Kioka, H; Masuda, M; Mine, T; Morita, T; Node, K; Okuda, K; Tamaki, S; Tsukamoto, Y; Yamada, T	1
Braunwald, E	1
Horwich, TB; MacLellan, WR	1
Kumar, V; Shah, RP; Singh, S	1
Schweiger, TA; Zdanowicz, MM	1
Amann, A; Buszewski, B; Ligor, M; Ligor, T; Miekisch, W; Nowaczyk, J; Olszowy, P; Schubert, JK; Wasiniak, B	1
Kitas, GD; Melas, N; Saratzis, A; Saratzis, N	1
Cho, KW; Choi, DH; Choi, HR; Cui, HZ; Kang, DG; Lee, HS	1
Bahcivan, M; Erenler, BH; Gol, MK; Keceligil, HT; Kolbakir, F; Yucel, S	1
Chang, SG; Jeon, SH; Lee, CH; Lee, JH; Lim, TJ; Min, GE; Yoo, KH	1
Chen, G; Deng, CQ; Wu, L	1
Emanueli, C; Fortunato, O; Madeddu, P; Mangialardi, G; Monopoli, A; Ongini, E; Spinetti, G	1
Chedgy, F; Howlett, DC; Inglis, C	1
Corcione, N; Di Pace, AL; Ferraro, P; Giordano, A; Monaco, M; Nappo, G; Polimeno, M; Romano, MF; Romano, S; Sorrentino, A	1
Lazareva, NV; Oshchepkova, EV	1
Buszman, PE; Buszman, PP; Kiesz, RS; Konkolewska, MD; Martin, JL; Radvany, MG; Szymanski, R; Wiernek, BK; Wiernek, SL	1
Davutoglu, V; Ercan, S; Sari, I	1
Eleftheriadou, I; Grigoropoulou, P; Katsilambros, N; Makrilakis, K; Margeli, A; Papassotiriou, I; Perrea, D; Tentolouris, N; Zoupas, C	1
Huo, Y; Peng, DQ; Yu, BL; Zhao, SP	1
Awada, C; Bonnet, S; Boucherat, O; Bourgeois, A; Breuils-Bonnet, S; Grobs, Y; Lemay, SE; Nadeau, V; Orcholski, M; Paulin, R; Provencher, S; Romanet, C; Shimauchi, K; Toro, V; Tremblay, E	1
Bendová, B; Büchler, T; Fiala, O; Filipovský, J; Fínek, J; Hora, M; Ostašov, P; Rozsypalová, A; Šorejs, O; Šustr, J; Trávníček, I	1

Reviews

4 review(s) available for pyrroles and cardiovascular agents

Article	Year
2004 drug approval highlights: FDA update. The Nurse practitioner, 2005, Volume: 30, Issue:2 Topics: Administration, Cutaneous; Amlodipine; Anti-Bacterial Agents; Antidepressive Agents; Bronchodilator Agents; Cardiovascular Agents; Drug Approval; Drug Combinations; Duloxetine Hydrochloride; Eplerenone; Estradiol; Excitatory Amino Acid Antagonists; Female; Gastrointestinal Agents; Heptanoic Acids; Humans; Ketolides; Male; Memantine; Osteoporosis, Postmenopausal; Pyrroles; Rifamycins; Rifaximin; Scopolamine Derivatives; Spironolactone; Thiophenes; Tiotropium Bromide; United States	2005
Atorvastatin and statins in the treatment of heart failure. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:17 Topics: Animals; Atorvastatin; Cardiovascular Agents; Drug Interactions; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Pyrroles; Treatment Outcome	2007
Vasopressin-receptor antagonists in heart failure. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, May-01, Volume: 65, Issue:9 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan	2008
Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence. Angiology, 2010, Volume: 61, Issue:2 Topics: Animals; Aortic Aneurysm, Abdominal; Atorvastatin; Blood Vessels; Cardiovascular Agents; Disease Progression; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Matrix Metalloproteinases; Models, Animal; Pyrroles; Risk Assessment; Simvastatin	2010

Trials

6 trial(s) available for pyrroles and cardiovascular agents

Article	Year
Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction. The American journal of cardiology, 2002, Oct-15, Volume: 90, Issue:8 Topics: Aged; Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cardiovascular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Pyrroles; Recurrence; Survival Rate	2002
Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation, 2004, Aug-31, Volume: 110, Issue:9 Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atorvastatin; Cardiovascular Agents; Cholesterol, LDL; Cilostazol; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Heparin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Tetrazoles; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional	2004
Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study. American heart journal, 2005, Volume: 150, Issue:2 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Atorvastatin; Cardiovascular Agents; Cholesterol, LDL; Comorbidity; Coronary Artery Disease; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Pyrroles; Radio Waves; Single-Blind Method; Treatment Outcome; Ultrasonography, Interventional	2005
Prevention of myocardial damage during coronary intervention. Cardiovascular & hematological disorders drug targets, 2006, Volume: 6, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Atorvastatin; Biomarkers; Cardiovascular Agents; Double-Blind Method; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Pyrroles; Treatment Outcome	2006
Effect of atorvastatin on baroreflex sensitivity in subjects with type 2 diabetes and dyslipidaemia. Diabetes & vascular disease research, 2014, Volume: 11, Issue:1 Topics: Aged; Atorvastatin; Baroreflex; Body Mass Index; Cardiovascular Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Diet, Fat-Restricted; Dyslipidemias; Female; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myalgia; Obesity; Patient Dropouts; Prospective Studies; Pyrroles; Risk Factors	2014
The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial. Atherosclerosis, 2014, Volume: 233, Issue:2 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; C-Reactive Protein; Cardiovascular Agents; China; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endpoint Determination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Prospective Studies; Pyrroles; Treatment Outcome	2014

Other Studies

31 other study(ies) available for pyrroles and cardiovascular agents

Article	Year
Inhibitory effect of a novel antianginal agent, E4080, on ST segment elevation induced by vasopressin in anesthetized guinea pigs. Japanese journal of pharmacology, 1992, Volume: 60, Issue:2 Topics: Anesthesia; Animals; Benzopyrans; Cardiovascular Agents; Catechols; Clonidine; Coronary Vessels; Cromakalim; Electrocardiography; Guinea Pigs; Heart Rate; Imidazoles; In Vitro Techniques; Isosorbide Dinitrate; Male; Nifedipine; Pyrroles; Vasodilator Agents; Vasopressins	1992
Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:6 Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Benzopyrans; Blood Pressure; Cardiovascular Agents; Coronary Circulation; Coronary Disease; Cromakalim; Decanoic Acids; Diltiazem; Dogs; Female; Glyburide; Heart; Heart Rate; Hydroxy Acids; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Oxygen Consumption; Potassium Channels; Pyrroles; Rats; Rats, Inbred Strains	1990
Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil. European journal of pharmacology, 1988, Aug-02, Volume: 152, Issue:3 Topics: 4-Aminopyridine; Aminopyridines; Animals; Benzopyrans; Cardiovascular Agents; Cromakalim; Guanidines; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Pinacidil; Potassium Channels; Procaine; Pyrroles; Rabbits; Rubidium Radioisotopes; Tetraethylammonium Compounds; Vasodilator Agents	1988
Comparison of the cromakalim antagonism and bradycardic actions of a series of novel alinidine analogues in the rat. Naunyn-Schmiedeberg's archives of pharmacology, 1994, Volume: 350, Issue:2 Topics: Animals; Benzopyrans; Cardiovascular Agents; Clonidine; Cromakalim; Heart Rate; In Vitro Techniques; Male; Potassium Channels; Pyrroles; Rats; Structure-Activity Relationship	1994
A bradycardic agent, UL-FS 49, increases atrial force and decreases ventricular force in isolated, perfused heart preparations of dogs. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:2 Topics: Acetylcholine; Adenosine; Animals; Atrial Function; Benzazepines; Benzopyrans; Cardiovascular Agents; Cromakalim; Dogs; Heart Atria; Heart Ventricles; In Vitro Techniques; Myocardial Contraction; Perfusion; Potassium Channels; Pyrroles; Sinoatrial Node; Ventricular Function	1993
Activators of sodium, calcium and potassium channels modulate the cardiac effects of quinidine in vitro. Pharmacology & toxicology, 1995, Volume: 77, Issue:5 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Azetidines; Benzopyrans; Calcium Channel Agonists; Cardiotonic Agents; Cardiovascular Agents; Cromakalim; Drug Combinations; Guinea Pigs; Heart; Heart Atria; Hemodynamics; In Vitro Techniques; Male; Papillary Muscles; Potassium Channels; Pyrroles; Quinidine; Sodium Channels	1995
Scavenger effect of experimental and clinically used cardiovascular drugs. Journal of cardiovascular pharmacology, 2001, Volume: 38, Issue:5 Topics: Anti-Arrhythmia Agents; Antioxidants; Carbazoles; Cardiovascular Agents; Carvedilol; Erythrocytes; Free Radical Scavengers; Humans; Indoles; Male; Methylphenazonium Methosulfate; Mexiletine; Propanolamines; Pyrroles; Sotalol	2001
Rhabdomyolysis with concurrent atorvastatin and diltiazem. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:10 Topics: Acute Disease; Acute Kidney Injury; Atorvastatin; Cardiovascular Agents; Chemical and Drug Induced Liver Injury; Diltiazem; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Rhabdomyolysis	2002
Drug interactions: gasoline and matches. The Canadian journal of cardiology, 2003, Volume: 19, Issue:1 Topics: Atorvastatin; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Databases, Factual; Drug Interactions; Heptanoic Acids; Pyrroles; Ticlopidine	2003
A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients. Circulation, 1954, Volume: 9, Issue:4 Topics: Autonomic Agents; Cardiovascular Agents; Hypertension; Muscle Relaxants, Central; Pyrroles	1954
A new class of antispasmodics with considerable activity. Journal of medicinal and pharmaceutical chemistry, 1959, Volume: 1, Issue:1 Topics: Cardiovascular Agents; Muscle Relaxants, Central; Parasympatholytics; Pyrroles	1959
Spasmolytic activity of 1-pyridylpyrroles. Journal of medicinal and pharmaceutical chemistry, 1960, Volume: 2 Topics: Cardiovascular Agents; Muscle Relaxants, Central; Parasympatholytics; Pyrroles	1960
SPASMOLYTIC 1,2,5-TRISUBSTITUTED PYRROLES. Journal of medicinal and pharmaceutical chemistry, 1962, Volume: 5 Topics: Cardiovascular Agents; Chemical Phenomena; Chemistry; Muscle Relaxants, Central; Parasympatholytics; Pyrroles; Research	1962
[ACTION OF AN ANTISPASMODIC PYRROLE DERIVATIVE ON THE CORONARY CIRCULATION]. Comptes rendus des seances de la Societe de biologie et de ses filiales, 1963, Aug-31, Volume: 157 Topics: Blood Circulation; Bradycardia; Cardiovascular Agents; Coronary Circulation; Coronary Vessels; Dogs; Metabolism; Muscle Relaxants, Central; Myocardium; Parasympatholytics; Pharmacology; Pyrroles; Research	1963
Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Atorvastatin; Azepines; Captopril; Cardiovascular Agents; Central Nervous System Agents; Chemical and Drug Induced Liver Injury; Chronic Disease; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Heptanoic Acids; Humans; Liver; Liver Diseases; Male; Middle Aged; Pyrroles; Registries; Spain	2006
Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy. The American journal of the medical sciences, 2006, Volume: 332, Issue:6 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Cardiomyopathy, Dilated; Cardiovascular Agents; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles; Ventricular Remodeling	2006
Reducing myocardial injury by minimizing imbalance between oxygen supply and demand. Anesthesiology, 2007, Volume: 107, Issue:1 Topics: Anesthesiology; Animals; Atorvastatin; Blood Pressure; Cardiovascular Agents; Coronary Disease; Dogs; Heart Diseases; Heart Rate; Heptanoic Acids; History, 20th Century; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Ischemia; Myocardial Revascularization; Necrosis; Oxygen; Pyrroles	2007
LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation products. Journal of pharmaceutical and biomedical analysis, 2008, Jul-15, Volume: 47, Issue:3 Topics: Aspirin; Atenolol; Atorvastatin; Cardiovascular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Drug Stability; Heptanoic Acids; Hydrochlorothiazide; Lisinopril; Pravastatin; Pyrroles; Simvastatin; Spectrometry, Mass, Electrospray Ionization	2008
Preparation and characterization of microporous fibers for sample preparation and LC-MS determination of drugs. Journal of separation science, 2009, Volume: 32, Issue:14 Topics: Cardiovascular Agents; Chromatography, High Pressure Liquid; Mass Spectrometry; Membranes, Artificial; Molecular Weight; Particle Size; Polymers; Porosity; Pyrroles; Reproducibility of Results; Solid Phase Microextraction; Surface Properties	2009
Aqueous extract of Zanthoxylum schinifolium elicits contractile and secretory responses via beta1-adrenoceptor activation in beating rabbit atria. Journal of ethnopharmacology, 2009, Nov-12, Volume: 126, Issue:2 Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Carbazoles; Cardiotonic Agents; Cardiovascular Agents; Cyclic AMP; Diltiazem; Heart Atria; Hemodynamics; Imidazoles; Plant Extracts; Plant Leaves; Plant Stems; Propanolamines; Propranolol; Pyrroles; Rabbits; Receptors, Adrenergic, beta-1; Stroke Volume; Zanthoxylum	2009
Reduced intimal hyperplasia in rabbits via medical therapy after carotid venous bypass. Texas Heart Institute journal, 2009, Volume: 36, Issue:5 Topics: Administration, Oral; Animals; Atorvastatin; Benzopyrans; Calcium Dobesilate; Cardiovascular Agents; Carotid Stenosis; Clopidogrel; Disease Models, Animal; Ethanolamines; Graft Occlusion, Vascular; Heptanoic Acids; Hyperplasia; Jugular Veins; Male; Nebivolol; Pyrroles; Rabbits; Ticlopidine; Tunica Intima; Vascular Surgical Procedures	2009
Life-threatening complications associated with the tyrosine kinase inhibitor sunitinib malate. Urologia internationalis, 2010, Volume: 85, Issue:4 Topics: Acute Kidney Injury; Angioplasty, Balloon, Coronary; Antineoplastic Agents; Carcinoma, Renal Cell; Cardiovascular Agents; Coronary Stenosis; Fatal Outcome; Female; Heart Failure; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Multiple Organ Failure; Protein Kinase Inhibitors; Pyrroles; Renal Dialysis; Sunitinib; Treatment Outcome	2010
The effects of BuYang HuanWu Decoction and its effective components on proliferation-related factors and ERK1/2 signal transduction pathway in cultured vascular smooth muscle cells. Journal of ethnopharmacology, 2011, Apr-26, Volume: 135, Issue:1 Topics: Alkaloids; Animals; Atorvastatin; Cardiovascular Agents; Cell Cycle; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Drugs, Chinese Herbal; Dual Specificity Phosphatase 1; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glycosides; Heptanoic Acids; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction	2011
Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells. British journal of pharmacology, 2011, Volume: 164, Issue:2b Topics: Aged; Anticholesteremic Agents; Apoptosis; Benzoates; Cardiovascular Agents; Cardiovascular Diseases; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Senescence; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Leukocytes, Mononuclear; Male; Middle Aged; Neovascularization, Physiologic; Nitrates; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Ornithine; Proto-Oncogene Proteins c-akt; Pyrroles; Stem Cells	2011
A case of recurrent ventricular tachycardia. BMJ (Clinical research ed.), 2011, Jun-01, Volume: 342 Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin	2011
Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cells. American journal of physiology. Heart and circulatory physiology, 2012, Jan-01, Volume: 302, Issue:1 Topics: Aged; Aged, 80 and over; Antigens, CD; Atorvastatin; beta Catenin; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Cyclin B; DNA Replication; Dose-Response Relationship, Drug; Drug-Eluting Stents; Endoglin; Heptanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Pyrroles; Receptors, Cell Surface; Tacrolimus; Time Factors	2012
[Painless myocardial ischemia in patient with extensive constrictive atherosclerosis of coronary arteries]. Kardiologiia, 2012, Volume: 52, Issue:2 Topics: Angioplasty; Anticholesteremic Agents; Asymptomatic Diseases; Atorvastatin; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Echocardiography; Electrophysiologic Techniques, Cardiac; Exercise Test; Heptanoic Acids; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Ischemia; Pyrroles; Severity of Illness Index; Treatment Outcome	2012
Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry). Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Sep-01, Volume: 82, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; Atherectomy; Atorvastatin; Cardiovascular Agents; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome	2013
Dramatic regression of three-vessel disease under statin treatment in patients with stable angina pectoris. Therapeutic advances in cardiovascular disease, 2012, Volume: 6, Issue:6 Topics: Angina, Stable; Atorvastatin; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pyrroles; Treatment Outcome	2012
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension. International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6 Topics: Animals; Antipsychotic Agents; Cardiovascular Agents; Cell Proliferation; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Repositioning; Female; Forkhead Box Protein O3; Gene Expression Regulation; Hemodynamics; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Survivin; Trifluoperazine	2021
Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line. Targeted oncology, 2021, Volume: 16, Issue:5 Topics: Aged; Carcinoma, Renal Cell; Cardiovascular Agents; Disease-Free Survival; Humans; Indazoles; Indoles; Kidney Neoplasms; Pyrimidines; Pyrroles; Retrospective Studies; Sulfonamides; Sunitinib; Treatment Outcome	2021